tm logo
AUTOLUS
Live/Registered
REGISTERED

on 04 Jul 2023

Last Applicant/ Owned by

191 Wood Lane London W12 7FP

GB

Serial Number

79338455 filed on 02th Mar 2022

Registration Number

7095476 registered on 04th Jul 2023

in the Principal Register

Correspondent Address

Rebecca Liebowitz

Rebecca Liebowitz

P.O. Box 34385

Washington DC 20043

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

AUTOLUS

Scientific and technological services and research and design relating thereto, namely medical research, scientific research, analysis and testing in the field of human and animal cell and gene therapies, pharmaceutical product development, research and development of new products; industrial analysis and research services in the field of cell and gene therapies ; medical and veterinary research s Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; veterinary services; medical and veterinary services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes namely, medical services relating to the removal, treatment and processing of human and animal cells; medical and veterinary services in the nature of reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services and research and design relating thereto, namely medical research, scientific research, analysis and testing in the field of human and animal cell and gene therapies, pharmaceutical product development, research and development of new products; industrial analysis and research services in the field of cell and gene therapies ; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services

Class [005]
Pharmaceutical Products


Medical and veterinary preparations for therapeutic purposes, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for cell therapy, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for gene therapy, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical preparations for the treatment of cancer; cells for medial or clinical use, namely cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof, for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; antibodies for medical purposes for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors, namely, culture media for cultivating and augmentation of human and animal cells; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes

Mark Details


Serial Number

No 79338455

Mark Type

No Service Mark

Attorney Docket Number

No 60895-576925

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
31st Oct 2023FINAL DECISION TRANSACTION PROCESSED BY IB
06th Oct 2023FINAL DISPOSITION NOTICE SENT TO IB
05th Oct 2023FINAL DISPOSITION PROCESSED
04th Oct 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04th Jul 2023REGISTERED-PRINCIPAL REGISTER
04th Jul 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th May 2023NOTIFICATION PROCESSED BY IB
18th Apr 2023PUBLISHED FOR OPPOSITION
18th Apr 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Apr 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB